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Gastro-oesophageal reflux disease is generally considered to be one of the commonest causes of chronic cough,
however randomised controlled trials of proton pump inhibitors have often failed to support this notion. This article
reviews the most recent studies investigating the mechanisms thought to link reflux and cough, namely laryngo-
pharyngeal reflux, micro-aspiration and neuronal cross-organ sensitisation. How recent evidence might shed light
on the failure of acid suppressing therapies and suggest new approaches to treating reflux related cough are also
discussed.Introduction
For over 30 years gastro-oesophageal reflux disease
(GORD) has been considered to be a cause of chronic
cough, either singly or in association with nasal disease
and/or asthma [1]. This was initially based on observa-
tional studies and small treatment trials of acid suppres-
sants [2-4]. However, it is the experience of many
clinicians that although some patients with chronic cough
do claim relief from acid-suppressants, the majority do
not. One of the difficulties in understanding why this
might be the case has been a shortage of high quality
evidence. Indeed a recent Cochrane review of various
treatments of GORD (H2 receptor antagonists, proton
pump inhibitors, motility agents, fundoplication or con-
servative treatments) for chronic cough found that meta-
analysis was not possible for most treatments in adults
and none in children due to poor trial design and lack
of appropriate data [5]. Nonetheless, a number of appro-
priately designed randomised controlled trials have been
completed assessing acid suppression with proton pump
inhibitor (PPI) therapy in adults with chronic cough [6-9].
The majority of these trials reported negative findings and
an intention-to-treat analysis of the pooled data found no
significant difference from placebo control. The reasons
for this lack of efficacy of PPI therapy in chronic cough
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distribution, and reproduction in any mediumi. GORD and chronic cough are both common
conditions affecting similar populations but without
a causal relationship, thus anecdotal reports of
responses to acid suppression are just placebo
responses,
ii. a variety of criteria have been used for patient
selection in studies of acid suppression, which may
not have either targeted or allowed the sub-group of
chronic cough patients to be identified that were
most likely to respond to acid suppression,
iii. the acidity of the refluxate may not be of major
importance in the pathophysiological processes
linking reflux and cough.
Hence to better understand the association between
GORD and cough requires a re-think of the possible
mechanisms connecting these conditions, and how these
might relate to sub-groups of patients with chronic
cough. The aim of this article is to review recent evi-
dence which might shed light on these mechanisms and
thus identify more appropriate management strategies
and treatment options for these patients along with
possible avenues for drug development.
Possible mechanisms linking cough and reflux: direct and
indirect
Mechanisms whereby gastro-oesophageal reflux events
can trigger coughing include i) direct stimulation of the
nerve terminals responsible for evoking cough either in
the larynx (laryngo-pharyngeal reflux) and/or bronchi
(microaspiration) and ii) indirect stimulation by activationCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Numbers of reflux events in a 24 hr period in an
unselected group of patients with chronic cough (CC n = 78)
and healthy volunteers (HV n = 20). Total numbers of events are
show and the number of acid events (pH < 4), number of non-acid
events (pH > 4), and the number of events extending into the
proximal oesophagus i.e. 16-18 cm above the lower
oesophageal sphincter. Data from [19].
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The concept that laryngopharyngeal reflux causes upper
airway symptoms has gained increasing attention in
recent years, despite the challenges of measuring gastro-
oesophageal reflux that extends up into the pharynx and
larynx. Reflux into the oesophagus is successfully mea-
sured by detecting changes in pH associated with the
acidity of the reflux events and more recently by com-
bining this with multi-channel intraluminal impedance
monitoring (MII/pH), allowing all reflux, whether liquid
or gas, acidic or not, to be detected. Impedance rings
allow measurement of the changes in conductance that
occur with the movement of liquid (low impedance) and
gas (high impedance) up into the oesophagus. In the
larynx and pharynx reflux measurement using these
technologies is more challenging. In the oesophagus, the
baseline impedance level remains relatively stable as the
impedance rings remain in contact with the oesophageal
mucosa. In contrast, the pharynx is an air filled cavity
and hence the baseline level of impedance is unstable,
fluctuating depending on whether the impedance rings
are in contact with the moist mucosa or in air. Moreover
differentiating a retrograde reflux event in the pharynx
from a swallow can be difficult and for both these rea-
sons agreement is poor between different observers ana-
lysing the traces [10]. Despite these difficulties some
investigators have reported pharyngeal reflux findings in
patients with chronic cough. One study using MII/pH
monitoring in the oesophagus and hypopharynx found
on average 2 pharyngeal liquid reflux episodes per
24 hrs in 17 patients [11] whilst another found none in a
group of 10 patients with chronic cough [12]. The latter
study however, did report that these patients exhibit
more weakly acid (pH 4–7) ‘gaseous’ pharyngeal reflux
events than controls or GORD patients but other inves-
tigators have suggested that gaseous pharyngeal reflux
cannot be analysed using impedance due to the air in
the pharynx [10].
Other techniques used to assess pharyngeal reflux in-
clude the Restech system, which detects changes in pH on
exposure to aerosol and liquid reflux in the oropharynx
and unlike standard pH electrodes can function in air.
Unfortunately two studies comparing the Restech with
simultaneous oesophageal MII/pH monitoring have found
the majority of pharyngeal pH drops are not associated
with oesophageal reflux events [13,14]. For example, in 10
patients with chronic cough, of the 39 oropharyngeal acid
events detected by the Restech, 43.6% were swallows, 38%
were not associated with any oesophageal MII/pH changes
and only 18% were clearly reflux events [13]. Indeedswallow artefacts are likely to be a particular problem in
patients with chronic cough who frequently sip fluids to
suppress their coughing. Lastly, subjective scoring systems
to document laryngeal appearances suggestive of LPR
have been used but have largely been discredited as the
specificity of findings [15] and inter-observer agreement
are poor [16-18].Proximal oesophageal reflux
In order to access the larynx and pharynx, refluxate
must first traverse the length of the oesophagus and also
breach the upper oesophageal sphincter. It could there-
fore be argued that the presence of excessive reflux in
the proximal oesophagus may predispose subjects to
LPR. However, the majority of studies both in unselected
patients with chronic cough or those in whom extra-
oesophageal causes have been excluded have shown that
the number and acidity of proximal oesophageal reflux
events is no different from healthy controls [19-21], who
exhibit a median of 8–9 reflux events per 24 hours (95th
percentile 30–31 events) [22,23], see Figure 1. Only one
study in a mixed group of patients with typical and atyp-
ical reflux symptoms, some of whom also had chronic
cough, found greater acid exposure in the proximal and
distal oesophagus of chronic cough patients compared
with those without cough [24]; but the average oeso-
phageal acid exposure was still within normal limits.
Perhaps more importantly we have found no correlation
between the number of proximally occurring reflux
events [19] and the frequency of coughing, suggesting
that the proximal extent of reflux events may not be im-
portant for provocation of cough.
Figure 2 Factors relevant to micro-aspiration of food and
refluxate into the airways; laryngeal reflexes include cough and
the laryngeal adductor reflex whereas pharyngeal reflexes are
reflexive pharyngeal swallow, the pharyngo-glottal closure
reflex and the pharyngo upper oesophageal sphincter
contractile reflex.
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Failure of the upper oesophageal sphincter (UOS) may
also increase the risk of refluxate reaching the larynx/
pharynx and two recent studies have investigated the role
of the UOS in cough. In a healthy control study, voluntary
coughing evoked a dramatic contractile response of the
UOS, assumed to be a protective reflex response to pre-
vent refluxate entering the pharynx [25]. Interestingly,
although this response was preserved in older healthy
volunteers (age > 70), the resting UOS pressure was lower,
suggesting a possible increased vulnerability to LPR out-
side cough events. The second study was a retrospective
review of patients with chronic cough undergoing high
resolution manometry and reflux monitoring, and showed
that although resting UOS pressures were within normal
limits, 9/34 subjects demonstrated a pathologically in-
creased residual or intra-bolus pressure at the UOS on
swallowing [26]. Although it might be speculated that this
might increase resistance to pharyngo-oesophageal flow,
its clinical significance remains to be established. This
study and several others have also reported ineffective
oesophageal peristalsis in chronic cough [27,28], with one
study finding twice the prevalence of ineffective peristalsis
in chronic cough compared with heartburn patients [28].
The presence of ineffective motility in chronic cough was
equally as likely in patients with and without acid reflux
[27], suggesting that dysmotility was not caused by abnor-
mal oesophageal acid exposure. However, this does not
exclude the possibility that poor or delayed oesophageal
clearance of refluxate might contribute to the risk of la-
ryngeal and pharyngeal exposure to refluxate or provoca-
tion of a broncho-oesophageal reflex.
Micro-aspiration
The risk of food or refluxate entering the airway is likely
to be a balance between the complex reflex responses
that have evolved to protect the airway and pathological
processes that increase pharyngeal/laryngeal exposure
to food and refluxate, such as impaired co-ordination of
swallowing, excessive laryngo-pharyngeal reflux and per-
haps also oesophageal dysmotility, see Figure 2. There-
fore microaspiration may occur as a consequence of
either impairment of the protective reflexes or excessive
challenges to these reflexes.
Protective pharyngeal and laryngeal reflexes
Studies infusing water into the hypopharynx of healthy
controls show that several protective reflexes (reflexive
pharyngeal swallow, the pharyngo-glottal closure reflex
and the pharyngo-upper oesophageal sphincter contractile
reflex) are all provoked well before volumes are reached
that are likely to spill into the airway [29]. Although si-
milar studies have yet to be performed in patients with
chronic cough, it is interesting to note that healthyvolunteers only cough when fluid enters the larynx. In pa-
tients with GORD, defined by abnormal oesophageal acid
exposure and/or oesophagitis [30], glottal closure and/or
swallow responses are evoked by much smaller hypo-
pharyngeal infusion volumes than in healthy controls,
whether acid or saline, suggesting a general hypersensitiv-
ity to pharyngeal fluid. Interestingly the same GORD sub-
jects exhibited diminished glottal closure in response to
laryngeal puffs of air (the laryngeal adductor reflex) com-
pared with controls, implying that whilst these patients
have exaggerated pharyngeal reflexes, laryngeal responses
may be impaired. The consequent risk of microaspiration
in these subjects is difficult to extrapolate. The same in-
vestigators also studied the laryngeal adductor reflex in
patients with chronic cough associated with GORD, again
defined by abnormal oesophageal acid exposure and/
or oesophagitis, with some improvement of cough with
previous acid suppression therapy [31]. As with the
GORD patients without cough, the chronic cough/GORD
patients had diminished laryngeal adductor responses
compared with healthy controls. Whether the laryngeal
adductor reflex is abnormal in chronic cough patients
without GORD and whether this deficit has any patho-
physiological consequences in the context of excessive
coughing remains unknown.
Reflex glottal closure has also been studied in response
to inhalation of the chemical irritant ammonia, measur-
ing the threshold for evoking a ‘glottic stop’, which is a
rapid transient glottal closure which can be detected by
a sudden drop in inspiratory flow during inhalation of
the vapour [32]. Unselected chronic cough patients had
heightened glottic stop responses to ammonia, but re-
sponses in sub-groups of patients were not reported and
very few subjects in the study had GORD related cough
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llenges are likely to evoke both pharyngeal and laryngeal
reflexes as the ammonia vapour cannot be directed at a
single receptive field.
Numerous studies have also documented that patients
with chronic cough also have exaggerated cough responses
to a variety of inhaled irritants (e.g. capsaicin and citric
acid) when compared with healthy controls [34]. Whilst
this hypersensitivity is generally interpreted as part of the
mechanism responsible for excessive coughing, it is likely
to also provide enhanced airway protection.
Airway pepsin and bile acids
As an alternative to exploring airway protective reflexes,
several investigators have sought evidence of refluxate
entering the airways by the detection of components of
gastric fluid. Most commonly pepsin and bile acids have
been measured in samples from the proximal (sputum)
and more distal airways (bronchoalveolar lavage (BAL)).
Whilst there is on-going debate about whether the
assays are reliable and which enzymes in refluxate are
most damaging to the airways, all studies that have in-
cluded patients with chronic cough, have failed to dem-
onstrate increased airway pepsin or bile acids compared
with healthy controls in sputum or BAL [19,35-37]. Of
note, pepsin concentrations in induced sputum samples
from chronic cough patients were found to negatively cor-
relate with objective cough frequency, unlike lavage fluid
pepsin, consistent with cough protecting the airways from
pepsin entry.
Summary of direct mechanisms
In summary, current evidence supporting direct provoca-
tion of coughing by refluxate stimulating the pharynx/lar-
ynx or airways is scant in patients with chronic cough.
Studies measuring the number of reflux events extending
in to the proximal oesophagus or pharynx suggest that, as
in healthy controls, very few such events occur. Pharyngeal
and laryngeal reflex responses have rarely been studied in
chronic cough patients, but it would seem unlikely that
impairment of the laryngeal adductor reflex confers a sig-
nificant aspiration risk, especially in the context of normal
swallowing and heightened cough and glottic stop re-
sponses to chemical stimuli. Indeed several studies have
indicated that very little pepsin or bile acid is present in
the airways of patients with chronic cough.
Indirect mechanisms
The shared vagal innervation of the oesophagus and air-
way and convergence of vagal afferents in the brainstem
provides a means via which reflux events confined to the
oesophagus may provoke airway responses in the form
of bronchoconstriction and cough.Temporal associations between reflux and cough
Most recent studies using pH/MII monitoring have sug-
gested that patients presenting with chronic cough have
physiological numbers of reflux events and oesophageal
acid exposure with the vast majority of events being
confined to the distal oesophagus (80%) [19-21]. None-
theless, a growing number of studies suggest that in a
significant number of patients coughing episodes seem
to be temporally linked to reflux events [20,21,38-40].
These studies have shown that between 20 and 48% of
patients has a positive symptom association probability
(SAP), for reflux preceding cough i.e. reflux-cough asso-
ciations. The SAP is calculated assuming reflux and cough
events are linked if they fall within 2 minutes of one an-
other, and the Fisher exact test is applied to assess whether
the number of linked events exceeds that expected by
chance alone. A SAP of 95% or greater is assumed to indi-
cate a positive association [41]. The appropriateness of the
2 minute window however needs further exploration.
As might be expected, studies using ambulatory acoustic
systems to record cough sounds [38,39] have reported
greater prevalence for both reflux-cough and cough-reflux
associations than other techniques, such as manometry
[20,21,40]. This is probably because it easier to identify
single coughs using acoustic systems than manometry,
where a single rapid pressure changes could represent
either cough or artefact, such as clearing of the throat,
and thus be rejected on a cautionary level by the observer.
Studies relying upon the patient to press an event marker
to document coughing episodes are the most unreliable,
missing 71% of audible cough events [42,43] and 61% of
manometric events [21].
We have recently shown using synchronized pH/impe-
dance and objective acoustic cough recording that over
70% of patients exhibit temporal relationships between
cough and distal oesophageal reflux, with 48% having
a positive SAP for reflux-cough associations (SAPR-C),
56% having a positive SAP for cough-reflux associations
(SAPC-R), and 32% both, raising the possibility of a self-
perpetuating cycle maintaining chronic cough [38]. Des-
pite slightly more patients having a positive SAPC-R than
SAPR-C, those with a positive SAPC-R had fewer temporally
linked events, suggesting that reflux triggering cough oc-
curs more often than cough triggering reflux. Notably as
in other studies, we also showed that the pH of the reflux
event linked to cough was not important, and that non-
acid events were as likely to be linked to cough as acid re-
flux events.
It is often assumed that the straining that occurs during
coughing can be responsible for provoking reflux events,
explaining cough-reflux associations. Reduction of the
time window from 2 minutes to 10 seconds for the SAP
calculations significantly reduced the percentage of pa-
tients exhibiting a positive SAPC-R to 24%, accounting for
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[44-46] that straining is not a major factor in reflux.
Oesophageal-bronchial reflex
The observation that coughs temporally associate with
preceding distal oesophageal reflux, supports a neuronal
mechanism linking reflux to cough. Neuronal oesophageal-
airway crosstalk most likely occurs where vagal afferents
converge and synapse within the brainstem in the nucleus
tractus solitarius (nTS). This has previously often been
described as the “oesophago-bronchial reflex”. Further
evidence supporting the presence of such a mechanism
comes from studies infusing acid into the distal oesophagus
reporting increased cough frequency [47] and cough reflex
sensitivity [48] in patients with chronic cough and associ-
ated GORD. Oesophageal acid infusion has not been found
to change cough reflex sensitivity in healthy volunteers
[48], suggesting that this pathway is usually dormant under
normal physiological conditions. This might imply that
patients exhibiting a positive SAPR-C have a central sensi-
tisation or neuroplastic change in these pathways permit-
ting oesophageal stimuli to modulate airway responses,
which is in keeping with the finding that SAPR-C positive
patients have heightened cough responses to inhaled citric
acid compared with negative SAPR-C subjects. Indeed a
difference in cough reflex sensitivity was the only factor
that discriminated between these groups, as the number
and acidity of reflux events and incidence of oesophagitis
at gastroscopy, were no different between groups. Only in
one study in patients with suspected GORD presenting
with otolaryngology symptoms has cough been suggested
to be associated with oesophagitis [49], but identification of
such disease appeared to be a poor predictor of treatment
response [50]. Other concomitant conditions potentially
contributing to cough, such as nasal disease, asthma,
eosinophilic bronchitis and bronchiectasis also had similar
prevalence in SAPR-C positive and negative subjects, sug-
gesting reflux may contribute to coughing independently
of other conditions.
Exactly how vagal pathways might become modified to
permit oesophageal-airway crosstalk is not known, but
there is evidence that similar processes are also present
in other conditions. For example, in asthma patients
several studies found that oesophageal acid infusion
can induce bronchoconstriction [51-54] and also cough
reflex hypersensitivity [55]. However a meta-analysis of
studies of PPI in asthma only found a small improve-
ment in peak flow, unlikely to be clinically important
[56]. Experimental oesophageal acid infusion studies
such as these have contributed to the expectation that
acid suppression therapy should be successful in patients
with cough/asthma and GOR, but it should be acknow-
ledged that the responses to oesophageal acid may be a
reflection of a more general visceral hypersensitivity ofthe oesophagus, which may occur in response to a va-
riety of stimuli and therefore does not necessarily impli-
cate oesophageal acid in the pathophysiology.
Sensitization within the nTS of the brain stem may also
be responsible for the reverse association i.e. cough in-
duced reflux. Vagal afferents from the proximal stomach
are responsible for transient lower oesophageal sphincter
relaxation (TLOSR), the main mechanism thought to be
responsible for reflux events in both health and disease
[57,58]. These afferents could conceivably be activated by
cough induced diaphragmatic motion, or by changes in
vagal tone associated with cough reflex activations to initi-
ate TLOSRs and thus reflux events, even several minutes
after cough [38].
Summary of indirect mechanisms
In summary, several studies from different laboratories
using MII/pH monitoring agree that intra-oesophageal
reflux in patients with chronic cough has similar charac-
teristics to that in healthy populations. However these
same studies have found statistically significant temporal
associations, suggesting cough follows reflux events more
frequently than would be expected by chance alone in up
to 50% of patients and independent of pH of the refluxate.
The most likely explanation for these associations is cross-
talk between airway and oesophageal afferents at their site
of convergence in the brainstem, suggesting in such pa-
tients, central nervous system mechanisms are responsible
for chronic cough.
Implications for treatment of gastro-oesophageal reflux in
chronic cough
Proton pump inhibitors
Given the available evidence, it is not surprising that
acid suppressants have demonstrated little overall thera-
peutic effect in most patients with chronic cough. Redu-
cing the acidity of reflux events in patients with positive
reflux-cough associations may be insufficient to prevent
these events provoking cough. Nonetheless, it remains
possible that a sub-group of patients might respond to
an appropriate dosing regimen and duration of treat-
ment with such medications; the trials of PPIs performed
to date have all been of insufficient size to identify such
a sub-group. A recent systematic review re-evaluated the
response of chronic cough to antacid therapy in trials
that included objective evidence of oesophageal acid
exposure on 24 hr pH monitoring [59]. Therapeutic gain
was greater in patients with evidence of pathological acid
reflux (range 12.5–35.8%) than in those without (range
0.0–8.6%), providing some evidence for the notion that
failure to include those patients most likely to respond
to acid suppression may have contributed to negative
findings in some trials. Indeed as most studies have
recruited subjects from secondary and tertiary care, the
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represented as a consequence of successful treatment in
primary care.
It remains to be seen whether patients with excessive
oesophageal acid exposure and positive reflux-cough as-
sociations have the best chance of responding to PPI treat-
ment. Future studies need also to be cognisant of the
problems with carryover effects observed in crossover
studies of PPIs [6] and that objective cough counts are
much more powerful than subjective scores for detecting
treatment effects and identifying responders from non-
responders [60].
Reflux inhibitors
Several novel compounds have recently been shown to
reduce the number of gastro-oesophageal reflux events
in both healthy controls and patients with reflux disease
by inhibition of TLOSRs [61] but none to date have been
assessed in patients extra-oesophageal reflux symptoms
such as chronic cough. The modes of action of reflux
inhibitors include gamma-aminobutyric acid B (GABAB)
receptor agonism and metabotropic glutamate receptor
5 (mGlu5) antagonists. The most extensively investigated
reflux inhibitor has been the GABAB receptor agonist
Lesogaberan, but unfortunately efficacy has been disap-
pointing as an add-on therapy to PPIs in patients with
typical symptoms of GORD [62,63]. Lesogaberan shares
its mechanism of action with Baclofen but with its main
activity in the peripheral rather than the central nervous
system, reducing side effects. Baclofen is thought to im-
prove symptoms in patients with chronic cough [64,65],
which could be by inhibiting reflux [66] and/or by re-
ducing the sensitivity of the cough reflex [67]. Recent
pre-clinical data suggests despite a peripheral mode of
action, Lesogaberan may have similar inhibitory effects
to Baclofen on experimentally induced cough [68]. It is
currently unknown whether reflux inhibitors may prove
to have clinically important therapeutic benefit in pa-
tients with chronic cough; nevertheless, they provide a
useful tool to further investigate the associations be-
tween cough and reflux.
Inhibition of the oesophago-bronchial reflex and central
sensitisation
Perhaps the most logical approach to treating reflux re-
lated cough might be to target the central neuronal sen-
sitisation responsible for reflux-cough associations, but at
present we know little about the relevant neuronal targets.
In pain hypersensitivity states, the N-Methyl-D-aspartate
(NMDA) receptor has been implicated in the development
of central sensitisation. Whilst dextromethorphan, a NM-
DA receptor antagonist, is one of the commonest over the
counter medicines used to treat cough, its efficacy is poor
[69]. Interestingly, the anti-tussive effect of this class ofagents seems to vary significantly between agents [70] and
we have found intravenous ketamine to be ineffective in
chronic cough patients [71]. It is possible though that
some of the centrally acting agents with evidence to
suggest efficacy in refractory cough, such as morphine and
gabapentin [72,73], may exert some of their effect by redu-
cing cough responses to oesophageal reflux, but mecha-
nistic studies have yet to address this possibility.
Surgical procedures
Laparoscopic fundoplication is as effective as long term
pharmacological treatment for patients with typical symp-
toms of reflux disease responsive to PPI treatment [74].
Surgical intervention for reflux in chronic cough is more
controversial as atypical symptoms, normal acid exposure
and persisting symptoms on PPI therapy have all been asso-
ciated with poorer outcomes [75]. Fundoplication reduces
both acid and non-acid reflux [76] and therefore has the
potential to reduce coughing provoked by reflux events.
Whilst many studies have reported series of patients with a
variety of atypical reflux symptoms, fewer have specifically
focussed on patients solely with chronic cough. The major-
ity of reports are retrospective reviews of outcomes for clin-
ical procedures in patients undergoing surgery for chronic
cough resistant to PPI therapy [77-80]. Most investigators
selected subjects with reflux-cough associations based on
patient registration of coughs, now known to be unreliable
[78,81-84]; some selected those with abnormal oesophgeal
acid exposure [79,85] and one used the patients history
alone [80]. Complete resolution of the cough was reported
in about 60% of subjects, compared with >90% in patients
with typical reflux [75]. These studies do not identify clear
predictors of a good response to surgery and rates of post
operative dysphagia were high in some series, ranging 19-
66%. It remains to be determined whether pH/impedance
parameters or acoustic reflux-cough associations might shed
light onwhich patientsmay benefit most from surgery.
Conclusions
Considerable progress has been made in recent years
towards a better understand of the processes which may
permit gastro-oesophageal reflux events to influence
cough. Similar work is needed in other respiratory condi-
tions if we are to begin to understand whether reflux
disease has a significant influence. The current body of
evidence largely supports the concept that neuronal cross-
talk between the oesophagus and airway drives the rela-
tionships between gastro-oesophageal reflux and cough,
however present technologies limit our ability to accur-
ately detect refluxate reaching the larynx, pharynx and
lower airways. Future strategies for treating patients with
cough reflux associations are likely to include treatments
to modulate the numbers of reflux events or the under-
lying neuronal hypersensitivity.
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